Li Deng

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A non-invasive, patient-derived organoid platform from uterine lavage fluid for modeling endometrial implantation and disease.

A non-invasive, patient-derived organoid platform from uterine lavage fluid for modeling endometrial implantation and disease.

Journal: Stem cell research & therapy

Published: February 22, 2026

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.

Journal: Nature communications

Published: September 13, 2025

Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancer.

Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancer.

Journal: Cancer

Published: July 18, 2025

Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study.

Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study.

Journal: EBioMedicine

Published: October 16, 2024

Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors.

Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors.

Journal: Chinese medical journal

Published: October 06, 2024

Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial.

Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial.

Journal: Med (New York, N.Y.)

Published: August 14, 2024

Natural and bio-engineered stem cell-derived extracellular vesicles for spinal cord injury repair: A meta-analysis with trial sequential analysis.

Natural and bio-engineered stem cell-derived extracellular vesicles for spinal cord injury repair: A meta-analysis with trial sequential analysis.

Journal: Neuroscience

Published: July 30, 2024

Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics.

Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics.

Journal: iScience

Published: March 19, 2024

Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study.

Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 23, 2024

Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations.

Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations.

Journal: BMC cancer

Published: February 18, 2024

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Journal: Cancer immunology, immunotherapy : CII

Published: December 25, 2023

Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics.

Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics.

Journal: Expert review of respiratory medicine

Published: September 30, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026